REFERENCES
- Naber KG, Weidner W. Prostatitis, epididymitis and orchitis. In: Cohen J, Powderly WG, ed. Infectious diseases. London: Mosby; 2004: 745-52.
- Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5: 492–518.
- European Association of Urology. Guidelines on urinary and male genital tract infections. Drukkerij Gelderland by, Arn-heim, The Nederlands, 2002: 49-56.
- Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999; 162: 369–75.
- Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Prostatitis Workshop, Bethesda, MD, 7–8 December 1995.
- Škerk V, Krhen I, Kalenid S, et al. Guidelines for antimi-crobial treatment and prophylaxis of urinary tract infections. Lijec Vjesn 2004; 126: 169–81.
- Krhen I, Skerk V, Schönwald S, Marekovid Z. Classifica-tion, diagnostics and treatment of prostatitis syndrome. Lijec Vjesn 2002; 124: 89–98.
- Bjerklund Johansen TE, Gruneberg RN, Guibert J, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998; 34: 457–66.
- Nickel JC, Moon T. Chronic bacterial prostatitis: an evolv-ing clinical enigma. Urology 2005; 66: 2–8.
- Magri V, Trinchieri A, Pozzi G, et al. Efficacy of repeated cycles of combination therapy for the eradication of infecting or-ganisms in chronic bacterial prostatitis. Int J Antimicrob Agents 2007; 29: 549–56.
- Škerk V, Tambid Andra§evid A, Andra§evid S, et al. ISKRA Guidelines on antimicrobial treatment and prophylaxis of urinary tract infections - Croatian National Guidelines 2007. URL: kittp://iskra.bfm.hr
- Škerk V. The treatment of sexually transmitted infections. PLIVA uêllgte Glasnik 2008;(26):1-4.
- Škerk V, Krhen I, Schönwald S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;24(Suppl 1):S53–6.
- Škerk V, Čajć V, Markovinovid L, et al. Etiology of chronic prostatitis syndrome in patients treated at the university hospital for infectious diseases “Dr. Fran Mihaljevi ” from 2003 to 2005. Coll Antropol 2006; 30( Suppl 2):145-9.
- Naber KG, Roscher K, Sotto H, Schaefer V. Oral lev-ofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents. 2008; 32: 145–53.
- Magri V, Trinchieri A, Ceriani I, Marras E, Perletti G. Erad-ication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome. Arch Ital Urol Androl 2007; 79: 93–8.
- Škerk V, Schönwald S, Granid J, et al. Chronic prostatitis caused by Trichomonas vaginalis—diagnosis and treatment. J Chemother 2002; 14: 537–8.